Does MEPOLIZUMAB Cause Pulmonary vasculitis? 143 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 143 reports of Pulmonary vasculitis have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.3% of all adverse event reports for MEPOLIZUMAB.
143
Reports of Pulmonary vasculitis with MEPOLIZUMAB
0.3%
of all MEPOLIZUMAB reports
57
Deaths
106
Hospitalizations
How Dangerous Is Pulmonary vasculitis From MEPOLIZUMAB?
Of the 143 reports, 57 (39.9%) resulted in death, 106 (74.1%) required hospitalization, and 136 (95.1%) were considered life-threatening.
Is Pulmonary vasculitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 143 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Pulmonary vasculitis?
LEVOFLOXACIN (200)
CALCIUM (197)
ALBUTEROL (194)
PREDNISONE (192)
MAGNESIUM (185)
METFORMIN (185)
FUROSEMIDE (183)
AZATHIOPRINE (178)
DOMPERIDONE (178)
TAMSULOSIN (174)
Which MEPOLIZUMAB Alternatives Have Lower Pulmonary vasculitis Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE